Arthur F. Ryan, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 100 shares at $775.63 ($78K) on 2026-02-09, disclosed to the SEC on 2026-02-11.
Seasonal sale ($78k) by Director — this insider has traded REGN in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $775.63 | 1 | $776 | 1.0% |
| 2 | $776.59 | 10 | $8K | 10.0% |
| 3 | $777.56 | 57 | $44K | 56.9% |
| 4 | $778.53 | 12 | $9K | 12.0% |
| 5 | $779.41 | 5 | $4K | 5.0% |
| 6 | $780.09 | 1 |
| $780 |
| 1.0% |
| 7 | $781.48 | 5 | $4K | 5.0% |
| 8 | $782.53 | 1 | $783 | 1.0% |
| 9 | $783.34 | 3 | $2K | 3.0% |
| 10 | $784.59 | 1 | $785 | 1.0% |
| 11 | $785.71 | 1 | $786 | 1.0% |
| 12 | $786.29 | 2 | $2K | 2.0% |
| 13 | $787.82 | 1 | $788 | 1.0% |
| Total | $778.53 avg | 100 | $78K | 100% |
| Filing → |
| REGN | SELL | 2026-04-03 | $78K | — | Filing → |
| REGN | SELL | 2026-03-03 | $79K | — | Filing → |
| REGN | SELL | 2024-10-03 | $105K | — | Filing → |